APP and Alzheimer disease: In the transgenic AD mouse model Tg2576, marked by mutant APP overexpression in the brain, melatonin treatment exhibited a trend of elevated Aβ levels in cervical and axillary lymph nodes, concomitant with a decreasing trend in brain Aβ [76].